BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2015
View Archived Issues
Genethon licenses CEVEC's lentivirus packaging cell line technology
Read More
Topica Pharmaceuticals to advance 10% luliconazole program into phase III development
Read More
Nestle Health Science licenses rights to Lipid Therapeutics' LT-02
Read More
Alector raises funds to advance immunomodulation approach for neurodegenerative diseases
Read More
Topline results from Apricus' phase IIa trial of RayVa for Reynaud's phenomenon
Read More
Arch Biopartners completes preclinical validation studies for AB-569
Read More
Infinity Pharmaceuticals adds IPI-549 to its pipeline for the treatment of solid tumors
Read More
FDA grants QIDP designation to Cempra's fusidic acid antibiotic
Read More
Shire's Intuniv approved in E.U. for ADHD
Read More
Novel MAb treats diabetes and fatty liver disease in obesity models
Read More
FDA accepts for review Heron's NDA resubmission for Sustol
Read More
FDA awards fast track designation to ZMapp for Ebola virus disease
Read More
Soluble Nogo-B improves angiogenesis in vitro
Read More
Cadila discloses BTK inhibitors
Read More
Takeda patents TBK1 inhibitors
Read More
Bristol-Myers Squibb presents MGAT2 inhibitors
Read More
Chinese researchers report discovery of compounds for psychiatric/neurological disorders
Read More
McGill University patent describes TC-PTP inhibitors
Read More
Pluristem and FDA agree development pathway for PLX-R18 in ARS
Read More
Beta-lactamase inhibitor CB-618 pharmacokinetics-pharmacodynamics characterized with other agents
Read More
Swissmedic approves Novartis's Entresto for heart failure
Read More
Clinigen and Neuraltus partner on managed access program for NP-001 in Europe
Read More
First clinical results disclosed for Enanta's EDP-239
Read More
New biomarkers described for liver transplant
Read More
Genmab and Novartis granted priority review for ofatumumab sBLA
Read More